Josephine Amie Koroma
Biographic Data
| ID | 9071432 |
|---|---|
| NAME | Josephine Amie Koroma |
| GIVEN NAMES | Josephine Amie |
| FAMILY NAME | Koroma |
| SIGNATURE | KOROMA J A |
| AFFILIATIONS | University of Sierra Leone |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Effect of the Covid-19 pandemic on drug-resistant tuberculosis treatment outcomes at a national referral hospital in Sierra Leone, 2017 to 2022
Sierra Leone is one of the 30 high TB burden countries in the world, with an incidence rate in 2023 of 273 per 100,000 population. Despite progress in case notification and treatment coverage, around 5,000 cases of TB in Sierra Leone are missing each year. The COVID-19 pandemic has further compounded these challenges. We highlight its effect on drug-resistant TB treatment outcomes. We conducted a retrospective cohort study of drug-resistant TB ca…
No prominent works on this page.
Effect of the Covid-19 pandemic on drug-resistant tuberculosis treatment outcomes at a national referral hospital in Sierra Leone, 2017 to 2022
Sierra Leone is one of the 30 high TB burden countries in the world, with an incidence rate in 2023 of 273 per 100,000 population. Despite progress in case notification and treatment coverage, around 5,000 cases of TB in Sierra Leone are missing each year. The COVID-19 pandemic has further compounded these challenges. We highlight its effect on drug-resistant TB treatment outcomes. We conducted a retrospective cohort study of drug-resistant TB ca…
Antibiotic Use and Resistance (1 work) · Diverse Scientific Research Studies (1 work) · Incidence (geometry) (1 work) · Logistic regression (1 work) · Odds (1 work) · Odds ratio (1 work) · Pandemic (1 work) · Referral (1 work) · Retrospective cohort study (1 work) · Tuberculosis (1 work)